An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

INTRODUCTION: Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-β 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-β 1a compared to low dose IFN-β 1a in severe COVID-19 cases. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi Darazam, Ilad, Hatami, Firouze, Mahdi Rabiei, Mohammad, Amin Pourhoseingholi, Mohamad, Shabani, Minoosh, Shokouhi, Shervin, Mardani, Masoud, Moradi, Omid, Javandoust Gharehbagh, Farid, Mirtalaee, Nasrinsadat, Negahban, Halimeh, Amirdosara, Mahdi, Zangi, Masoud, Hajiesmaeili, Mohammadreza, Kazempour, Muhanna, Shafigh, Navid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238656/
https://www.ncbi.nlm.nih.gov/pubmed/34224994
http://dx.doi.org/10.1016/j.intimp.2021.107916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238656/
https://www.ncbi.nlm.nih.gov/pubmed/34224994
http://dx.doi.org/10.1016/j.intimp.2021.107916

Ejemplares similares